From dermal exposure to internal dose

Journal of Exposure Science and Environmental Epidemiology

Volumn 17, Issue SUPPL. 1, 2007, Pages

  Van De Sandt, Johannes J M ^a   Dellarco, Mike ^b   Van Hemmen, Joop J ^a  

^a TNO   (Netherlands)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

(Q)SAR; Bioavailability; Dermal exposure; Internal dose; Modelling; Skin absorption

Indexed keywords

ALGORITHM; BIOAVAILABILITY; CONTAMINATION; DOSE RESPONSE; HUMAN; LAW; NONHUMAN; POPULATION EXPOSURE; REVIEW; RISK ASSESSMENT; SKIN ABSORPTION; SKIN PERMEABILITY; SKIN TOXICITY;

ANIMALS; BIOLOGICAL AVAILABILITY; CHEMICAL INDUSTRY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; EUROPEAN UNION; HUMANS; MODELS, ANIMAL; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PERMEABILITY; RISK ASSESSMENT; SKIN ABSORPTION;

ANIMALIA;

EID: 36949007894     PISSN: 15590631     EISSN: 1559064X     Source Type: Journal    
DOI: 10.1038/sj.jes.7500579     Document Type: Review

References (48)

1. Bouwman T., Cronin M.T.D., Bessems J.G.M., and Van de Sandt J.J.M. Evaluation of published QSARs for percutaneous absorption. Toxicol Lett (2006): 164: S322.
2. Brouwer D.H., Aitken R.J., Oppl R., and Cherrie J.W. Concepts of skin protection: considerations for the evaluation and terminology of the performance of skin protective equipment. J Occup Environ Hyg (2005): 2: 425-434.
3. p). Occupational and Environmental Exposures of Skin to Chemicals - 2005 (2005). Abstract for poster 25 http://www.cdc.gov/niosh/topics/skin/OEESC2/ AbPost025Buist.html.
4. Buist H.E., de Heer C., van Burgsteden J.A., and van de Sandt J.J.M. Dermatokinetics of didecyldimethylammonium chloride and the influence of some commercial biocidal formulations on its dermal absorption in vitro. Regul Toxicol Pharmacol (2007) (E-pub ahead of print).
5. CEFIC. CEFIC Workshop on methods to determine dermal permeation for human risk assessment. Research Report TM/04/07 December 2004 (2004), 1-86. http://www.iom-world.org/news/ppworkshop.php.
6. Cherrie J.W., and Robertson A. Biologically relevant assessment of dermal exposure. Ann Occup Hyg (1995): 39: 387-392.
7. Chilcott R.P., Barai N., Beezer A.E., Brain S.I., Brown M.B., Bunge A.L., Burgess S.E., Cross S., Dalton C.H., Dias M., Farinha A., Finnin B.C., Gallagher S.J., Green D.M., Gunt H., Gwyther R.L., Heard C.M., Jarvis C.A., Kamiyama F., Kasting G.B., Ley E.E., Lim S.T., McNaughton G.S., Morris A., Nazemi M.H., Pellett M.A., DU Plessis J., Quan Y.S., Raghavan S.L., Roberts M., Romonchuk W., Roper C.S., Schenk D., Simonsen L., Simpson A., Traversa B.D., Trottet L., Watkinson A., Wilkinson S.C., Williams F.M., Yamamoto A., and Hadgraft J. Inter- and intralaboratory variation of in vitro diffusion cell measurements: an international multicenter study using quasi-standardized methods and materials. J Pharm Sci (2005): 94: 632-638.
8. Cleek R.L., and Bunge A.L. A new method for estimating dermal absorption from chemical exposure. 1. general approach. Pharm Res (1993): 10(4): 497-506.
9. Cronin M.T.D. The prediction of skin permeability using quantitative structure-activity relationships (QSARs). In: Riviere J. (Ed.). Dermal Absorption Models in Toxicology and Pharmacology. CRC Press: Boca Raton, FL, USA, 2005.
10. De Heer C., Wilschut A., Stevenson H., and Hakkert B.C., Guidance document on the estimation of dermal absorption according to a tiered approach: an update. Zeist, Netherlands, TNO report V98.1237 (1999), 1-42. To be obtained through J.J.M. van de Sandt ( han.vandesandt@tno.nl).
11. EC. Technical guidance document (TGD) on risk assessment in support of Commission Directive 93/67/EEC on risk assessment for new notified substances. European Commission, Part, 1 (2003), 1-303.
12. EC. Guidance document on dermal absorption. European Commission, Sanco/222/2000 rev. 7 (2004), 1-15.
13. 14C cortisol in man. J Invest Dermatol (1967): 48: 181-183.
14. Fitzpatrick D., Corish J., and Hayes B. Modelling skin permeability for risk assessment - the future. Chemosphere (2004): 55: 1309-1314.
15. Flynn G.L. Physicochemical determinants of skin absorption. In: Gerrity T.R., Henry C.J. (Eds.). Principles of Route-to-Route Extrapolation for Risk Assessment. Elsevier: New York, 1990, pp 93-127.
16. Global Net on "Consumer Exposure Modelling". Report of Workshop No. 1 on "Dermal transfer and penetration algorithms". (2006). (Stylianos Kephalopoulos, Joop J. van Hemmen, Katinka van der Jagt). EUR 22521 EN/1 - DG Joint Research Centre, Institute for Health and Consumer Protection, Luxembourg: Office for Official Publications of the European Communities.
17. Hueber-Becker F., Nohynek G.J., Dufour E.K., Meuling W.J.A., de Bie AThHJ, Toutain H., and Bolt H.M. Occupational exposure of hairdressers to [(14)C]-para-phenylenediamine-containing oxidative hair dyes: a mass balance study. Food Chem Toxicol (2006) (E-pub ahead of print).
18. ICH (International conference on harmonization). Guideline for good clinical practise. ICH Harmonised Tripartite Guideline (1996), 1-57. http://www.ich.org.
19. IPCS. International Programme on Chemical Safety, Environmental Health Criteria 235: dermal absorption. United Nations Environment Programme, World Health Organisation (2006), WHO Press: Geneva, Switzerland.
20. Jakasa Y., Mohammadi N., Kruse J., and Kezic S. Percutaneous absorption of neat and aqueous solutions of 2-butoxyethanol in volunteers. Int Arch Occup Environ Health (2004): 77: 79-84.
21. Kroes R., Renwick A.G., Feron V., Galli C.L., Gibney M., Greim H., Guy R.H., Lhuguenot J.C., and Van de Sandt J. Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients, (2007) (submitted).
22. Kromhout H., Fransman W., Vermeulen R., Roff M., and Van Hemmen J.J. Variability of task-based dermal exposure measurements from a variety of workplaces. Ann Occup Hyg (2004): 48: 187-196.
23. Kruse J., Golden D., Wilkinson S., Williams F., Kezic S., and Corish J. Analysis, interpretation, and extrapolation of dermal permeation data using diffusion-based mathematical models. Pharm Sci (2007): 96: 682-703.
24. Moss G.P., Dearden J.C., Patel H., and Cronin M.D. Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol In Vitro (2002): 16: 299-317.
25. OECD. OECD guideline for the testing of chemicals. Skin Absorption: In Vivo Method (2004a): 427. Adopted: 13 April 2004, pp 1-8, OECD publishing, Paris.
26. OECD. OECD guideline for the testing of chemicals. Skin Absorption: In Vitro Method (2004b): 428. Adopted 13 April 2004, pp 1-8, OECD publishing, Paris.
27. OECD. Guidance document for the conduct of skin absorption studies. OECD Series on Testing and Assessment (2004c) Number 28 ENV/JM/MONO (2004), pp 21-31, OECD publishing, Paris.
28. Potts R.O., and Guy R.H. Predicting skin permeability. Pharm Res (1992): 9: 663-669.
29. RISKOFDERM. Special Issue. Ann Occup Hyg (2004): 48: 183-297.
30. Ross J.S., and Shah J.C. Reduction in skin permeation of N,N-diethyl-m-toluamide (DEET) by altering the skin/vehicle partition coefficient. J Control Release (2000): 67: 211-221.
31. SCCP (Scientific Committee on Consumer Products). Basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients. Document SCCP/ 0790/06 Adopted by the SCCP on March 28 (2006).
32. Scheuplein R.J., and Blank I.H. Permeability of the skin. Physiol Rev (1971): 51: 702-747.
33. Southwell J.D., Barry B.W., and Woodford R. Variations in permeability of human skin within and between specimens. Int J Pharm (1984): 18: 299-309.
34. Steiling W., Kreutz J., and Hofer H. Percutaneous penetration/dermal absorption of hair dyes in vitro. Toxicology In Vitro (2001): 15: 565-570.
35. Touraille G.D., McCarley K.D., Bunge A.L., Marty J.P., and Guy R.H. Percutaneous absorption of 4-cyanophenol from freshly contaminated soil in vitro: effects of soil loading and contamination concentration. Environ Sci Technol (2005): 39: 3723-3731.
36. US EPA. Dermal exposure assessment: principles and applications. EPA/600/8-91/011B (1992), 1-389. http://www.epa.gov/nceawww1/pdfs/derexp.pdf.
37. US EPA. Health effects test guidelines. US Environmental Protection Agency, OPPTS 870.7600. Dermal penetration (1998), 1-12. http://www.epa.gov/ opptsfrs/OPPTSHarmonized/870HealthEffectsTestGuidelines/Series/870-7600.pdf.
38. US EPA. In vitro dermal absorption rate testing of certain chemicals of interest to the occupational safety and health administration; Final rule. Fed Regist (2004a): 69(80): 22402-22441.
39. US EPA. Risk assessment guidance for superfund volume I: human health evaluation manual (part E, supplemental guidance for dermal risk assessment). EPA540/R/99/005 (2004b), 1-156. http://www.epa.gov/oswer/riskassessment/ragse/ pdf/20041101pa rte.pdf.
40. Van de Sandt J.J.M., van Burgsteden J.A., Carmichael P.L., Dick I., Kenyon S., Korinth G., Larese F., Limasset J.C., Maas W.J.M., Montomoli L., Nielsen J.B., Payan J.-P., Robinson E., Sartorelli P., Schaller K.H., Wilkinson S.C., and Williams F.M. In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul Toxicol Pharmacol (2004): 39: 271-281.
41. Van Hemmen J.J., and Brouwer D.H. Assessment of dermal exposure to chemicals. Sci Total Environm (1995): 168: 131-141.
42. Van Hemmen J.J., and Van der Jagt K.E. Generic Operator exposure databases. In: Franklin C.A., Worgan J.P. (Eds.). Occupational and Residential Exposure Assessment for Pesticides. Wiley and Sons: UK, 2005.
43. Van Ravenzwaay B., and Leibold E. The significance of in vitro rat skin absorption studies to human risk assessment. Toxicology In Vitro (2004): 18: 219-225.
44. Walker J.D., Whittaker C., and McDougal J.N. Role oft he TSCA Interagency Testing Committee in Meeting the US Government's Data Needs: Designating chemicals for percutaneous absorption testing. In: Marzulli F.N., Maibach H.I. (Eds.). Dermatotoxicology, 5th edn Hemisphere Publishing Corporation: Washington, DC, (1996), 371-381.
45. Wester R.C., and Maibach H.I. Regional variation in percutaneous absorption. In: Bronaugh R.L., Maibach H.I. (Eds.). Percutaneous Absorption: Drugs - Cosmetics - Mechanism - Methodology. (3rd ed., rev. and expanded). [Drugs and pharmaceutical science Vol. 97] Marcel Dekker Inc: New York, (1999), pp 107-116.
46. Wheeler J.P., and Warren N.D. A Dirichlet Tesselation-based sampling scheme for measuring whole-body exposure. Ann Occup Hyg (2002): 46: 209-217.
47. WMO (World Medical Association). Declaration of Helsinki (Ethical principles for medical research involving human subjects) (2004), 1-5. http://www.wma.net.
48. Zartarian V., Bahador T., and McKone T. Adoption of an official ISEA glossary. J Expo Anal Environ Epidemiol (2005): 15: 1-15.